CLOV vs. AUR
CLOV (Clover Health Investments, Corp.) and AUR (Aurora Innovation, Inc.) are both stocks. CLOV operates in Healthcare Plans (Healthcare), while AUR operates in Information Technology Services (Technology). Over the past 5 years, CLOV returned -18.17%/yr vs -8.42%/yr for AUR. At a 0.40 correlation, their price movements are largely independent.
Performance
CLOV vs. AUR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CLOV achieves a 115.32% return, which is significantly higher than AUR's 67.19% return.
CLOV
- 1D
- -1.56%
- 1M
- 42.54%
- YTD
- 115.32%
- 6M
- 100.79%
- 1Y
- 78.80%
- 3Y*
- 78.71%
- 5Y*
- -18.17%
- 10Y*
- —
AUR
- 1D
- -2.13%
- 1M
- -9.19%
- YTD
- 67.19%
- 6M
- 56.97%
- 1Y
- 18.45%
- 3Y*
- 39.11%
- 5Y*
- -8.42%
- 10Y*
- —
CLOV vs. AUR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CLOV Clover Health Investments, Corp. | 115.32% | -25.40% | 230.85% | 2.43% | -75.01% | -56.84% |
AUR Aurora Innovation, Inc. | 67.19% | -39.05% | 44.16% | 261.16% | -89.25% | 12.60% |
Correlation
The correlation between CLOV and AUR is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.36 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.33 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since May 10, 2021 | 0.40 |
Fundamentals
CLOV:
$2.64B
AUR:
$12.51B
CLOV:
-$0.11
AUR:
-$0.44
CLOV:
1.18
AUR:
3.03K
CLOV:
7.78
AUR:
6.37
CLOV:
$2.21B
AUR:
$4.00M
CLOV:
$939.14M
AUR:
$163.00M
CLOV:
-$55.21M
AUR:
-$882.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLOV vs. AUR — Risk / Return Rank
CLOV
AUR
CLOV vs. AUR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Aurora Innovation, Inc. (AUR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLOV | AUR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.82 | ||
| Sortino ratioReturn per unit of downside risk | +0.95 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.10 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 1.43 | 0.44 | +0.99 |
| Martin ratioReturn relative to average drawdown | 2.60 | 0.73 | +1.87 |
Loading charts...
Drawdowns
CLOV vs. AUR - Drawdown Comparison
The maximum CLOV drawdown since its inception was -97.19%, roughly equal to the maximum AUR drawdown of -93.34%. Use the drawdown chart below to compare losses from any high point for CLOV and AUR.
Loading charts...
Drawdown Indicators
| CLOV | AUR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.19% | -93.34% | -3.85% |
Max Drawdown (1Y)Largest decline over 1 year | -55.50% | -42.53% | -12.97% |
Max Drawdown (3Y)Largest decline over 3 years | -64.73% | -63.00% | -1.73% |
Max Drawdown (5Y)Largest decline over 5 years | -95.35% | -93.34% | -2.01% |
Current DrawdownCurrent decline from peak | -77.16% | -62.48% | -14.68% |
Average DrawdownAverage peak-to-trough decline | -76.59% | -67.37% | -9.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.42% | 25.43% | +4.99% |
Volatility
CLOV vs. AUR - Volatility Comparison
Clover Health Investments, Corp. (CLOV) has a higher volatility of 26.10% compared to Aurora Innovation, Inc. (AUR) at 18.13%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than AUR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLOV | AUR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.10% | 18.13% | +7.97% |
Volatility (6M)Calculated over the trailing 6-month period | 43.24% | 49.00% | -5.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.33% | 62.36% | +8.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.99% | 90.79% | -13.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 85.67% | 89.66% | -3.99% |
Dividends
CLOV vs. AUR - Dividend Comparison
Neither CLOV nor AUR has paid dividends to shareholders.
Financials
CLOV vs. AUR - Financials Comparison
This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Aurora Innovation, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CLOV and AUR have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLOV has higher volatility (26.10%) compared to AUR (18.13%). In terms of maximum drawdown, CLOV dropped -97.19% vs AUR's -93.34%.
CLOV currently has the higher Sharpe Ratio (1.12 vs 0.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CLOV and AUR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer